ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.97
0.10%
US Tech 100
20,011.20
-0.57%
S&P 500
5,917.11
0.00%
US Dollar vs CAD
1.39766
0.04%
Bitcoin
97,654.54
3.47%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Genfit (GNFT) Share Price

Genfit

Genfit (GNFT)

Genfit SA
4.015
-0.01
( -0.25% )
Updated: 03:41:10
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
4.015
Bid
4.005
Ask
4.015
Volume
63,968
4.00 Day's Range 4.08
2.90 52 Week Range 5.86
Market Cap
200.087M
Previous Close
4.025
Open
4.025
Last Trade
10
@
4.015
Last Trade Time
03:41:10
Financial Volume
-
VWAP
-
Average Volume (3m)
329,918
Shares Outstanding
49,834,983
Dividend Yield
-
PE Ratio
-6.99
Earnings Per Share (EPS)
-0.58
Revenue
38.68M
Net Profit
-28.89M

About Genfit

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.genfit.com
Headquarters
Loos, Nord, Fra
Founded
-
Genfit is listed in the Pharmaceutical Preparations sector of the Euronext with ticker GNFT. The last closing price for Genfit was 4.03 €. Over the last year, Genfit shares have traded in a share price range of 2.90 € to 5.86 €.

Genfit currently has 49,834,983 shares outstanding. The market capitalization of Genfit is 200.59 € million. Genfit has a price to earnings ratio (PE ratio) of -6.99.

Ask ADVFN Intelligence (AI)

GNFT Latest News

More News

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024 Programme PBC (sous licence Ipsen) : Ipsen présentera de nouvelles...

November 13 2024
UK Regulatory

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch...

November 13 2024
UK Regulatory

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from...

November 13 2024
GlobeNewswire Inc.

GENFIT : Information financière du troisième trimestre 2024

GENFIT : Information financière du troisième trimestre 2024 Trésorerie et équivalents de trésorerie s’élevant à 96,0 millions d’euros au 30 septembre 202459,7 millions d’euros de revenus des neuf...

November 07 2024
UK Regulatory

GENFIT Reports Third Quarter 2024 Financial Information

GENFIT Reports Third Quarter 2024 Financial Information Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30...

November 07 2024
UK Regulatory

GENFIT Reports Third Quarter 2024 Financial Information

Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30, 2024, including the €48.7 million milestone invoiced in...

November 07 2024
GlobeNewswire Inc.

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval Lille (France), Cambridge...

September 23 2024
UK Regulatory

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA américaine

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA...

September 23 2024
UK Regulatory

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 23, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to...

September 23 2024
GlobeNewswire Inc.

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société Trésorerie et équivalents de trésorerie s’élevant à 61,6 millions d’euros au 30 juin 2024 n’incluant...

September 19 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.875-17.89366053174.894.95543890694.21865211DE
4-1.115-21.73489278755.135.6343089324.84695135DE
120.2055.380577427823.815.863.6253299184.88489033DE
260.1955.104712041883.825.863.473368284.60069643DE
520.86527.46031746033.155.862.92661904.1943634DE
1560.83726.33731906863.1785.862.7462144903.94029017DE
260-9.885-71.115107913713.920.962.7463087035.60555573DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALMASMastrad
0.0136 €
(58.14%)
976.27k
BIDSGascogne DS
0.0028 €
(55.56%)
40.05k
SOISOITEC
75.20 €
(18.43%)
193.43k
HYLHyloris Pharmaceuticals SA
5.88 €
(13.51%)
36.48k
ATODSAtos SE
0.0046 €
(12.20%)
12.01M
EBUSEbusco Holding NV
0.918 €
(-25.12%)
1.47M
VACBSPierre & Vacances
0.048 €
(-14.29%)
427
EMGDSEuromedis DS
0.0088 €
(-12.00%)
2.65k
ALVETTheraVet SA
0.0804 €
(-10.67%)
28.93k
ALAIRGroupe Airwell
1.43 €
(-9.49%)
1.57k
ATODSAtos SE
0.0046 €
(12.20%)
12.01M
ALVERVergnet
0.005 €
(4.17%)
7.64M
ALTDTonner Drones
0.0102 €
(10.87%)
6.92M
BCPBanco Comercial Portugues SA
0.4354 €
(-1.00%)
6.87M
ATOAtos SE
0.1767 €
(-8.21%)
2.8M

Discussion

View Full Feed
Golden Cross Golden Cross 2 minutes ago
$ILLR ✨ ILLR Update: Former Head of Product at TikTok Sean Kim joins Triller Group
https://www.youtube.com/watch?v=2Nq9YJiZt8U

[yt]2Nq9YJiZt8U[/yt]
ILLR
XenaLives XenaLives 3 minutes ago
LOL!!! DFCO is a typical BONAR pump and dump.

No fundamentals at all here.....
DFCO
Methinks Methinks 3 minutes ago
https://www.widepoint.com/widepoint-certifies-new-proprietary-mobileanchor-digital-credential-for-mobile-devices/
Found this, and thanks, Bull_Dolphin. I look forward to hearing more about the DAAS partnership.
WYY
aniyahsbednar aniyahsbednar 3 minutes ago
Official Website... https://cutt.ly/BeKWwPJc

Vital Grow XL Gummies are formulated to enhance male performance, vitality, and overall wellness. Designed with convenience and natural ingredients in mind, these gummies aim to provide benefits like improved stamina, testosterone support,
Golden Cross Golden Cross 3 minutes ago
$ILLR ✨ ILLR Update: Former Head of Product at TikTok Sean Kim joins Triller Group
https://www.youtube.com/watch?v=2Nq9YJiZt8U

[yt]2Nq9YJiZt8U[/yt]
ILLR
Methinks Methinks 7 minutes ago
https://www.widepoint.com/widepoint-certifies-new-proprietary-mobileanchor-digital-credential-for-mobile-devices/

"Direct Integration: WidePoint’s MobileAnchor™ generates a digital credential directly on the device, can leverage device-specific security features, such as hardware-base
diggitydoodle diggitydoodle 11 minutes ago
A lot of giving opinions, predicting, hoping & wishing what this tickers great CEO will do. Based on reading into things without those things specifically being written in any of the reports coming out.
This great CEO can't put out timely fins. And, doesn't give updates, even of the most gen
RNVA
TheFinalCD TheFinalCD 12 minutes ago
RMSG 7
CRAZY SWINGS FROM
55- TO 2.65 TO 10.70

RMSG
https://finance.yahoo.com/news/real-messenger-nova-vision-acquisition-210800321.html
RMSG
aniyahsbednar aniyahsbednar 13 minutes ago
Official Website... https://cutt.ly/keKQ376J

MaxBoost Plus is a premium male enhancement supplement designed to help men improve stamina, vitality, and overall confidence. Using a powerful blend of natural ingredients, it supports testosterone levels, blood flow, and energy, empowerin
TrendTrade2016 TrendTrade2016 13 minutes ago
BDPT FIRST TRIP REVERSE SPLIT TO HIT...GET READY CLOWNS...THIS IS THE BEGINNING TO THEBIGGEST OTC RS CAMPAIGN IN A DECADE
BDPTD
Truth_is_a_tool Truth_is_a_tool 17 minutes ago
I feel a disturbance in the force too lol and I’m going to go ahead and agree. I feel we will have a PR in less than 3 hours.
KBLB
Truth_is_a_tool Truth_is_a_tool 19 minutes ago
Hi M4N , my concern was that it was in the latest prospectus that just came out but you and Mojo are probably right that it’s just a copy and paste. Either way im not really concerned as it doesn’t change my view that this company will have a breakout soon enough , whether it’s this year or the next
KBLB
Bull_Dolphin Bull_Dolphin 21 minutes ago
Yay!!!!

https://www.breitbart.com/entertainment/2024/11/20/ellen-degeneres-leaves-united-states-flees-to-england-over-trump-election/
Minddoc7 Minddoc7 22 minutes ago
Coinbase CEO Brian Armstrong Perfect For Crypto Czar Role - Charles Hoskinson

"Cardano founder Charles Hoskinson has thrown his weight behind Coinbase CEO Brian Armstrong as the best choice for a potential “crypto czar” position in the Trump administration.

The informal
COIN
Seminole Red Seminole Red 23 minutes ago
good job
cowtown jay cowtown jay 25 minutes ago
How much longer can it be before we start to see detailed stock quotes on this site (advfn) again? So many pieces of the puzzle are starting to be displayed, they have got to be near the point where they are snapped together. We've got to be generating revenue by now.

https://www.ad
aniyahsbednar aniyahsbednar 27 minutes ago
Official Website... https://cutt.ly/qeKQMuOM

VitalRize Male Enhancement is a cutting-edge supplement designed to help men regain their stamina, boost testosterone levels, and improve overall confidence. With a blend of natural and clinically tested ingredients, VitalRize offers a holi
aniyahsbednar aniyahsbednar 41 minutes ago
Official Website... https://cutt.ly/2eKQSgxD

Green Regimen Energy and Focus is a dietary supplement designed to enhance energy levels and improve mental focus naturally. Crafted with clean, plant-based ingredients, it is often marketed as a solution for those looking to maintain peak
meshcan meshcan 41 minutes ago
Great investment in R&D. Nasrat has said they will only develop the big drugs who have $1B+ annual sale. So we should see our pipeline get better and better.
ELTP
MoneyMaker111 MoneyMaker111 42 minutes ago
GME to close at or above $30 todayyy?

$GME ( Hyper Bullish / Apish )
#GME ( Hyper Bullish / Apish )
GME

Your Recent History

EU
GNFT
Genfit
BOV
PETR4
PETROBRAS PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved